Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 481 to 490 of 1630
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK MIA 44893 Insp GMP/GDP 44893/296341-0013[H] GMPC

SOHO FLORDIS UK LIMITED TRADING AS POTTERS, 1 BOTANIC COURT, MARTLAND PARK, WIGAN, WN5 0JZ, UNITED KINGDOM

UNITED KINGDOM
UK MIA 17087 Insp GMP/GDP/IMP 17087/30671-0033[H] GMPC

ALLERGY THERAPEUTICS (UK) LIMITED, DOMINION WAY, WORTHING, BN14 8SA, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 17087 Insp GMP/GDP/IMP 17087/30671-0033[I] GMPC

ALLERGY THERAPEUTICS (UK) LIMITED, DOMINION WAY, WORTHING, BN14 8SA, UNITED KINGDOM

UNITED KINGDOM
UK MIA 17087 Insp GMP/GDP/IMP 17087/13114-0006[H] GMPC

ALLERGY THERAPEUTICS 2, UNIT A/B, DOMINION WAY, WORTHING, BN14 8NW, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 17087 Insp GMP/GDP/IMP 17087/13114-0006[I] GMPC

ALLERGY THERAPEUTICS 2, UNIT A/B, DOMINION WAY, WORTHING, BN14 8NW, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 101 Insp IMP 101/19062596-0010[I] GMPC

NOVARTIS PHARMACEUTICALS UK LIMITED, 2ND FLOOR, THE WEST WORKS BUILDING, WHITE CITY PLACE, 195 WOOD LANE, LONDON, W12 7FQ, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 34874 Insp IMP 34874/1940634-0008[I] GMPC

CANCER RESEARCH UK FORMULATION UNIT, UNIVERSITY OF STRATHCLYDE, 161 CATHEDRAL STREET, GLASGOW, G4 0RE, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 11387 Insp IMP 11387/6280106-0004[I] GMPC

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST, CLINICAL RESEARCH FACILITY, 15TH FLOOR, TOWER WING, GUY'S HOSPITAL, GREAT MAZE POND, LONDON, SE1 9RT, UNITED KINGDOM

UNITED KINGDOM
UK MIA 15632 Insp GMP 15632/31154-0029[H] GMPC

PHARMAPAC (UK) LIMITED, UNITS 20 TO 24 AND 29 AND 30, VALLEY ROAD BUSINESS PARK, BIRKENHEAD, CH41 7EL, UNITED KINGDOM

UNITED KINGDOM
UK ManA 15632 Insp GMP 15632/31154-0029[V] GMPC

PHARMAPAC (UK) LIMITED, UNITS 20 TO 24 AND 29 AND 30, VALLEY ROAD BUSINESS PARK, BIRKENHEAD, CH41 7EL, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX